https://www.selleckchem.com/products/fr180204.html
8%, p=0.006). The 5-year survival was 87% and 55% at 10 years. In patients undergoing CABG and mitral valve intervention for IMR, long-term mortality remains high. There was no difference in short- or long-term mortality between repair and replacement although recurrence of at least moderate mitral regurgitation was significantly higher with mitral valve repair. In patients undergoing CABG and mitral valve intervention for IMR, long-term mortality remains high. There was no difference in short- or long-term mortality between repair and
Like
Comment
Share
